Nnukwu Ọcha Pharmaceutical Paclitaxel ntụ ntụ Paclitaxel CAS 33069-62-4

Nkọwa dị mkpirikpi:

Yunnan Hande bụ onye nrụpụta paclitaxel API na China China nke gafekwara asambodo FDA US, nweta asambodo CEP ọgwụ Europe, wee nweta asambodo GMP ọgwụ China.Anyị nwere ike ịnye paclitaxel eke dị elu nke ọma ruo ogologo oge.


Nkọwa ngwaahịa

Mkpado ngwaahịa

Ozi ngwaahịa

Aha:Paclitaxel eke

Nọmba CAS:33069-62-4

Usoro kemịkalụ:C47H51NO14

Nkọwapụta:99%-102%

Agba:ọcha ma ọ bụ ihe fọrọ nke nta ka ọ bụrụ ntụ ntụ ọcha

Isi mmalite:Taxus yunnanensis, Taxus chinensis

Ụdị:API

Usoro nchọpụta&ndụ shelf

Ụzọ nchọpụta:HPLC

Nkwenye:Afọ ise

Oge nyochagharị:Ọnwa 36

Ọnọdụ nchekwa:mechiri emechi, chebe ya pụọ ​​​​na ọkụ, akọrọ, na-achịkwa na okpomọkụ nke ụlọ (15-30ºC)

Ọrụ

Paclitaxel bụ metabolite nke abụọ sitere n'okike dịpụrụ adịpụ ma sachaa site na ogbugbo nke gymnosperm Taxus chinensis.Achọpụtara ya na ụlọ ọgwụ na-enwe mmetụta dị mma na-egbochi tumor.

Ngwa

Ejiri ya na nkà mmụta ọgwụ, ejirila ya mee ihe n'ọtụtụ ebe n'ịgwọ ọrịa kansa ara, ọrịa cancer ovarian na ụfọdụ ọrịa isi na olu na ọrịa cancer akpa ume.

Ọrụ anyị

1.Ngwaahịa:Nye elu-edu, elu-ọcha osisi wepụ, ọgwụ akụrụngwa, na ọgwụ intermediates.

2.Ọrụ nka:Mwepụta ahaziri iche nwere nkọwa pụrụ iche dị ka ihe ndị ahịa chọrọ.

Ụlọ ọrụ Hande 

Yunnan hande Biotechnology Co., Ltd., tọrọ ntọala na August 1993, bụ ụlọ ọrụ teknụzụ dị elu nke ọkachamara na nyocha na mmepe biotechnology.Mgbe ọtụtụ afọ nke mmepe gasịrị, hande eguzobewo usoro dị mma zuru oke, na-achịkwa àgwà ngwaahịa dịka ụkpụrụ dị elu si dị, ma mee ka uru mmepụta nke mmepụta ihe dị elu.Ngwaahịa ya agafeela asambodo nke iwu na ụkpụrụ mba dị iche iche, wee bụrụ onye nrụpụta akụrụngwa akụrụngwa nke na-eme onye ọ bụla nwee ahụ iru ala.

Ụlọ ọrụ Hande

Bụrụ onye na-ebubata akụrụngwa na ụlọ ọrụ na-eguzosi ike n'ezi ihe!

Nnọọ ịkpọtụrụ m site na izipu email namarketing@handebio.com


  • Nke gara aga:
  • Osote: